# Development of fast penumbral imaging in acute ischemic stroke

> **NIH NIH R01** · EMORY UNIVERSITY · 2021 · $419,475

## Abstract

PROJECT SUMMARY/ABSTRACT
Imaging is an essential tool to guide stroke patient management. Recent DAWN and DEFUSE-3 trials have
provided the definitive evidence that imaging is critical to guide late endovascular therapy (EVT), underscoring
the need to transition from onset time-based to tissue-based treatment. However, it has been estimated that
the majority of stroke patients (~70%) presenting 6-24 hrs with NIH Stroke Scale (NIHSS) over 6 are not
DAWN and/or DEFUSE-3 eligible (Desai et al. J Neurointerv Surg. 2018; 10:1033-37). The 2018 American
Heart Association Stroke Early Management Guidelines pointed out that it is “… reasonable to incorporate
collateral flow status into clinical decision making in some candidates to determine eligibility for mechanical
thrombectomy.” Tissue metabolic MRI is a surrogate biomarker of the collateral flow status that is promising to
address this clinical need. We will develop fast pH and diffusion kurtosis imaging (DKI) and evaluate their value
for guiding reperfusion therapy in experimental stroke models.
During the previous funding cycle, we made steady progress in developing new stroke MRI techniques. We
developed pH-specific imaging based on magnetization transfer and relaxation-normalized amide proton
transfer (MR-APT) MRI (Guo et al. Neuroimage 2016;242-9). Using filament middle cerebral artery occlusion
rats, we refined the perfusion/diffusion-weighted imaging (PWI/DWI) lesion mismatch for the metabolic
penumbra and benign oligemia (Wang et al. Neuroimage 2019;610-7). Our acute stroke patient study showed
that the volumes of acute DKI lesions have a higher correlation coefficient than those on the apparent diffusion
coefficient (ADC) maps with 1-month follow-up T2 images (Yin et al. Radiology 2018:651-7). This echoes the
recent study from NINDS investigators who reported: “ADC evolution in patients with early, complete
revascularization, now more commonly seen with EVT, is strikingly different from our historical understanding.”
(Hsia et al., Stroke. 2019;50:2086-92) We hypothesize that new fast MRI techniques refined tissue-clock helps
delineate ischemic tissue, predict tissue outcomes in permanent stroke, and guide reperfusion treatment. It is
urgent to test the refined tissue-clock, in the presence of common stroke comorbidities and in the experimental
setting, before initiating future prospective clinical trials. Briefly, we will develop robust fast pH and DKI stroke
imaging (Aim 1), establish the spatiotemporal evolution of the refined MRI in MCAO rats (Aim 2), and test
tissue-clock-guided reperfusion in rats of common stroke comorbidities of age and diabetes (Aim 3). The
success of the project will lay the groundwork for future clinical trials to test advanced imaging-guided stroke
treatment in the clinic.

## Key facts

- **NIH application ID:** 10205181
- **Project number:** 5R01NS083654-08
- **Recipient organization:** EMORY UNIVERSITY
- **Principal Investigator:** Phillip Zhe Sun
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $419,475
- **Award type:** 5
- **Project period:** 2013-06-01 → 2025-05-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10205181

## Citation

> US National Institutes of Health, RePORTER application 10205181, Development of fast penumbral imaging in acute ischemic stroke (5R01NS083654-08). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10205181. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*